Showing 51 - 60 of 36,141
Background: The Disability in Strategies for Care (DISC) study was the first large randomised controlled trial to compare alternative treatment strategies in the acute treatment of migraine. With 835 patients in its intention-to-treat efficacy analysis, DISC compared a stratified care strategy,...
Persistent link: https://www.econbiz.de/10005449017
Barrett's oesophagus is a premalignant complication that occurs in approximately 10% of patients with gastro-oesophageal reflux disease (GORD). In patients with Barrett's oesophagus, the risk of adenocarcinoma of the oesophagus approaches 0.5% per patient-years. Therefore, practice guidelines...
Persistent link: https://www.econbiz.de/10005449033
Objective: To assess the cost effectiveness of nasal calcitonin (Miacalcin(R)) compared with no therapy, alendronate or etidronate in the treatment of postmenopausal women with previous osteoporotic fracture. Design and setting: Meta-analysis followed by economic analysis. Perspective: A...
Persistent link: https://www.econbiz.de/10005449053
Pharmacological treatment of hypertension has been shown to reduce the risk of stroke, coronary events, heart failure and progression of renal disease. However, rates of successful blood pressure control remain low among treated patients while antihypertensive medication represents a large and...
Persistent link: https://www.econbiz.de/10005449057
A growing body of recent work has identified several problems with economic evaluations undertaken alongside controlled trials that can have potentially serious impacts on the ability of decision makers to draw valid conclusions. At the same time, the use of cost-effectiveness models has been...
Persistent link: https://www.econbiz.de/10005449064
Objective: To estimate the potential savings in overall cardiovascular disease (CVD) treatment costs for the US population with coronary artery disease (CAD) resulting from the use of amlodipine. Study design and methods: Using patient-level data from a retrospective analysis of the Prospective...
Persistent link: https://www.econbiz.de/10005449078
Background: In the Balloon Angioplasty and Anticoagulation Study (BAAS), coumarins added to routine aspirin therapy before coronary angioplasty reduced cardiac events at the cost of a slightly higher risk of bleeding complications. Objective: To determine the cost effectiveness of coumarin...
Persistent link: https://www.econbiz.de/10005449091
Objectives: 1. To project vaccine parameters, economic consequences and market size associated with HIV-1 vaccination of infants in sub-Saharan Africa through the Expanded Program on Immunisation (EPI); and 2. to assess threshold values for price and effectiveness. Study design and methods:...
Persistent link: https://www.econbiz.de/10005449097
Objective: The principle aim of this study was to generate a league table of drugs considered by the Australian Pharmaceutical Benefits Advisory Committee (PBAC) for reimbursement. The table was used to test the hypothesis that decisions made by the PBAC are consistent with the maxim of economic...
Persistent link: https://www.econbiz.de/10005449122
Objective: To evaluate the relationship between how much a new cardiovascular therapy improves clinical outcomes over current therapies and how much more it can cost while still remaining Design: We developed a decision model to predict the 6-month cumulative cost savings and increased life...
Persistent link: https://www.econbiz.de/10005449137